Medical Affairs Consultancy · New Zealand

Strategic medical
affairs leadership
when it matters
most.

Supporting pharmaceutical organisations to design and execute robust launch strategies — enabling credible scientific leadership with patients at the centre.

Dr Alia Mahgoub — Ascentra Medical

Founder & Principal

Dr Alia Mahgoub
MD · MPH · Medicines Dev.

Launch ExcellenceScientific EngagementPost-Launch ExecutionPHARMAC AccessMedical Affairs StrategyAdvisory BoardsField Medical EnablementEvidence-Led DialogueLaunch ExcellenceScientific EngagementPost-Launch ExecutionPHARMAC AccessMedical Affairs StrategyAdvisory BoardsField Medical EnablementEvidence-Led Dialogue
Dr Alia Mahgoub — Ascentra Medical

Enabling credible
scientific leadership.

I am a Medical Doctor with over 10 years' experience in Medical Affairs, combining clinical expertise with postgraduate training in Medicines Development and Public Health.

My work spans pre-launch, peri-launch, and early post-launch Medical Affairs strategy and execution — translating evidence into impactful medical plans that place patients at the centre of every decision.

I partner with pharmaceutical organisations navigating the New Zealand market, bringing deep knowledge of local governance, PHARMAC access pathways, and the clinical dialogue required to support confident, ethical launch execution.

MD (Medical Doctor) — Clinical Foundation
Postgraduate Diploma in Medicines Development — Stellenbosch University
Master of Public Health (MPH) — University of Edinburgh
10+ years in Medical Affairs · NZ market expertise

Three pillars of
launch excellence.

I work with pharmaceutical organisations at the moments that define launch success — from strategy design through to post-launch optimisation.

01

Launch Excellence

Launch-ready Medical Affairs strategy and integrated planning aligned to global objectives, New Zealand governance, and local clinical and access pathways.

Enquire →
02

Launch Scientific Engagement

Evidence-led scientific engagement and advisory boards aligned to launch milestones, generating actionable insight to inform confident, real-time launch decisions.

Enquire →
03

Post-Launch Execution

Field medical enablement and ongoing execution support through launch and the first year post-launch, optimising impact as clinical practice and access evolve.

Enquire →

Science-led.
Patient-centred.
Execution-ready.

I combine clinical insight with business acumen to design Medical Affairs strategies that are both scientifically rigorous and commercially aligned — always with patients as the anchor of every decision.

Medical Affairs Strategy

Integrated medical plans aligned to therapeutic area evidence, HCP needs, and funding access requirements.

Scientific Dialogue & Advisory

Credible external engagement including advisory boards, KOL relationships, and evidence generation planning.

Access & Funding Considerations

Medical Affairs contribution to access, PHARMAC pathways, and guideline positioning in the NZ environment.

Field Medical Enablement

Equipping MSL teams and field medical functions for credible, evidence-based scientific exchange at launch.

10+Years Medical Affairs experience
3Postgraduate qualifications
NZMarket-specialist, Auckland based
360°Pre · peri · post-launch coverage

Launch Phase Coverage

Pre-Launch
Peri-Launch
Post-Launch

"My work focuses on translating evidence into impactful execution that places patients at the centre — contributing to guidelines, recommendations, access and funding considerations with the ultimate aim of positively influencing patient outcomes."

— Dr Alia Mahgoub, Founder

Let's discuss your
next launch.

Reach out to explore how Ascentra Medical can support your Medical Affairs strategy — whether you're planning a New Zealand launch, building your scientific engagement programme, or need senior medical leadership at a pivotal moment.